Apple shares jumps 4% after TD Cowen analysts reiterated their "Buy" rating and raised price target to $250; here's what is going for the iPhone maker
TD Cowen analysts forecast moderate growth in the March 2025 quarter. They expect mid-single-digits percentage growth ...
CACI to Participate in TD Cowen 46th Annual Aerospace and Defense Conference
CACI International Inc (NYSE: CACI) announced today that it will participate in the TD Cowen 46th Annual Aerospace and ...
History suggests markets are more primed for a pullback than not, says TD Cowen's Jeff Solomon
Jeff Solomon, TD Cowen president, joins 'Money Movers' to discuss the underlying tone of the AI drama this week, what to ...
bovnews2h
Why Did Arthur J. Gallagher & Co. (AJG) Stock See 2.04% Surge in the Last 90 Days?
Arthur J. Gallagher & Co. (AJG) stock saw a decline, ending the day at $293.41 which represents a decrease of $-2.59 or -0.87% from the prior close of $296. The stock opened at $297.05 and touched a ...
bovnews4h
Exxon Mobil Corp (XOM) Stock Sees Market Value Hit $474.85 billion: What Are the Implications?
Exxon Mobil Corp (XOM) stock saw a decline, ending the day at $108.04 which represents a decrease of $-2.13 or -1.93% from the prior close of $110.17. The stock opened at $110.41 and touched a low of ...
Upstream44m
Guyana production spikes for Hess in fourth quarter
Guyana production for Hess surged by 52% in the fourth quarter to 195,000 barrels per day of oil, the US operator revealed ...
1 Wall Street Analyst Sees Salesforce Stock Going to $400. Is It a Buy?
Salesforce ( CRM 0.70%) has been a leader in cloud software since its inception. In fact, founded as a cloud software company ...
Atlassian price target raised to $280 from $220 at TD Cowen
TD Cowen analyst Derrick Wood raised the firm’s price target on Atlassian (TEAM) to $280 from $220 and keeps a Hold rating on the shares. The ...
Celsius 'growth story has cooled' says TD Cowen
TD Cowen expressed concerns about valuation. “If Celsius can’t demonstrate a path back to growth, it could end up being ...
Nasdaq22d
KalVista initiated with a Buy at TD Cowen
TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...
reinsurancene2d
U.S. casualty reserve development the biggest wildcard for reinsurers in 2025, say analysts
Moody's insurance executives have identified U.S. casualty reserve development as the biggest wildcard for reinsurers in 2025 ...
TD Cowen starts on ConocoPhillips with 'buy' rating on growth drivers
Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE: COP) with a "Buy" rating and a $125 price target, ...